SHL Telemedicine Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	57.08	59	49.58	40.16	41.88
Revenue Growth (YoY)	-3.26%	18.99%	23.45%	-4.11%	-
Cost of Revenue	31.81	31.81	24.99	19.52	18.42
Gross Profit	25.26	27.19	24.59	20.64	23.46
Selling, General & Admin	26.81	28.15	21.56	16.94	15.24
Research & Development	5.26	3.79	2.99	2.76	2.51
Other Operating Expenses	2.2	0.42	0.55	0.55	0.63
Operating Expenses	34.27	32.36	25.09	20.25	18.38
Operating Income	-9.01	-5.17	-0.5	0.4	5.08
Interest Expense / Income	1.79	2.36	13.35	0.64	0.57
Other Expense / Income	-4.63	-8.54	-0.2	-0.32	-0.26
Pretax Income	-6.17	1.02	-13.66	0.08	4.77
Income Tax	0.89	1.1	0.46	-0.2	-0.92
Net Income	-7.06	-0.08	-14.11	0.28	5.7
Net Income Growth	-	-	-	-95.12%	-
Shares Outstanding (Basic)	16	14	14	-	-
Shares Change	13.08%	-	-	-	-
EPS (Basic)	-0.43	-0.01	-1.00	0.03	0.54
EPS (Diluted)	-0.54	-0.49	-1.00	0.03	0.54
EPS Growth	-	-	-	-94.44%	-
Free Cash Flow	-6.99	-6.98	-3.07	2.91	8.88
Free Cash Flow Per Share	-0.43	-0.48	-0.21	-	-
Gross Margin	44.26%	46.08%	49.60%	51.40%	56.02%
Operating Margin	-15.78%	-8.76%	-1.00%	0.99%	12.13%
Profit Margin	-12.36%	-0.13%	-28.46%	0.69%	13.60%
Free Cash Flow Margin	-12.24%	-11.83%	-6.20%	7.25%	21.19%
Effective Tax Rate	-	107.44%	-	-261.04%	-19.34%
EBITDA	3.32	10.51	5.08	5.65	9.26
EBITDA Margin	5.81%	17.81%	10.25%	14.06%	22.10%
Depreciation & Amortization	7.69	7.13	5.38	4.93	3.92
EBIT	-4.37	3.38	-0.3	0.72	5.34
EBIT Margin	-7.66%	5.72%	-0.61%	1.79%	12.75%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).